Literature DB >> 25840412

High-level Gpr56 expression is dispensable for the maintenance and function of hematopoietic stem and progenitor cells in mice.

Tata Nageswara Rao1, Jonathan Marks-Bluth2, Jessica Sullivan1, Manoj K Gupta3, Vashe Chandrakanthan2, Simon R Fitch4, Katrin Ottersbach4, Young C Jang1, Xianhua Piao5, Rohit N Kulkarni3, Thomas Serwold3, John E Pimanda2, Amy J Wagers6.   

Abstract

Blood formation by hematopoietic stem cells (HSCs) is regulated by a still incompletely defined network of general and HSC-specific regulators. In this study, we analyzed the role of G-protein coupled receptor 56 (Gpr56) as a candidate HSC regulator based on its differential expression in quiescent relative to proliferating HSCs and its common targeting by core HSC regulators. Detailed expression analysis revealed that Gpr56 is abundantly expressed by HSPCs during definitive hematopoiesis in the embryo and in the adult bone marrow, but its levels are reduced substantially as HSPCs differentiate. However, despite enriched expression in HSPCs, Gpr56-deficiency did not impair HSPC maintenance or function during steady-state or myeloablative stress-induced hematopoiesis. Gpr56-deficient HSCs also responded normally to physiological and pharmacological mobilization signals, despite the reported role of this GPCR as a regulator of cell adhesion and migration in neuronal cells. Moreover, Gpr56-deficient bone marrow engrafted with equivalent efficiency as wild-type HSCs in primary recipients; however, their reconstituting ability was reduced when subjected to serial transplantation. These data indicate that although GPR56 is abundantly and selectively expressed by primitive HSPCs, its high level expression is largely dispensable for steady-state and regenerative hematopoiesis.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25840412      PMCID: PMC4439311          DOI: 10.1016/j.scr.2015.02.001

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  41 in total

1.  "Stemness": transcriptional profiling of embryonic and adult stem cells.

Authors:  Miguel Ramalho-Santos; Soonsang Yoon; Yumi Matsuzaki; Richard C Mulligan; Douglas A Melton
Journal:  Science       Date:  2002-09-12       Impact factor: 47.728

2.  Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors.

Authors:  Jonah Riddell; Roi Gazit; Brian S Garrison; Guoji Guo; Assieh Saadatpour; Pankaj K Mandal; Wataru Ebina; Pavel Volchkov; Guo-Cheng Yuan; Stuart H Orkin; Derrick J Rossi
Journal:  Cell       Date:  2014-04-24       Impact factor: 41.582

3.  GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion.

Authors:  Sumana Shashidhar; Gustavo Lorente; Usha Nagavarapu; April Nelson; Jane Kuo; Jeramiah Cummins; Karoly Nikolich; Roman Urfer; Erik D Foehr
Journal:  Oncogene       Date:  2005-03-03       Impact factor: 9.867

4.  Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor.

Authors:  S Neben; K Marcus; P Mauch
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

5.  A stem cell molecular signature.

Authors:  Natalia B Ivanova; John T Dimos; Christoph Schaniel; Jason A Hackney; Kateri A Moore; Ihor R Lemischka
Journal:  Science       Date:  2002-09-12       Impact factor: 47.728

6.  G protein-coupled receptor-dependent development of human frontal cortex.

Authors:  Xianhua Piao; R Sean Hill; Adria Bodell; Bernard S Chang; Lina Basel-Vanagaite; Rachel Straussberg; William B Dobyns; Bassam Qasrawi; Robin M Winter; A Micheil Innes; Thomas Voit; M Elizabeth Ross; Jacques L Michaud; Jean-Claude Déscarie; A James Barkovich; Christopher A Walsh
Journal:  Science       Date:  2004-03-26       Impact factor: 47.728

7.  Hematopoietic stem cells are uniquely selective in their migratory response to chemokines.

Authors:  Douglas E Wright; Edward P Bowman; Amy J Wagers; Eugene C Butcher; Irving L Weissman
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

8.  Whole-transcriptome analysis of endothelial to hematopoietic stem cell transition reveals a requirement for Gpr56 in HSC generation.

Authors:  Parham Solaimani Kartalaei; Tomoko Yamada-Inagawa; Chris S Vink; Emma de Pater; Reinier van der Linden; Jonathon Marks-Bluth; Anthon van der Sloot; Mirjam van den Hout; Tomomasa Yokomizo; M Lucila van Schaick-Solernó; Ruud Delwel; John E Pimanda; Wilfred F J van IJcken; Elaine Dzierzak
Journal:  J Exp Med       Date:  2014-12-29       Impact factor: 14.307

9.  GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells.

Authors:  Kam-Wing Ling; Katrin Ottersbach; Jan Piet van Hamburg; Aneta Oziemlak; Fong-Ying Tsai; Stuart H Orkin; Rob Ploemacher; Rudi W Hendriks; Elaine Dzierzak
Journal:  J Exp Med       Date:  2004-10-04       Impact factor: 14.307

10.  Molecular signatures of proliferation and quiescence in hematopoietic stem cells.

Authors:  Teresa A Venezia; Akil A Merchant; Carlos A Ramos; Nathan L Whitehouse; Andrew S Young; Chad A Shaw; Margaret A Goodell
Journal:  PLoS Biol       Date:  2004-09-28       Impact factor: 8.029

View more
  9 in total

1.  GPR56 contributes to the development of acute myeloid leukemia in mice.

Authors:  D Daria; N Kirsten; A Muranyi; M Mulaw; S Ihme; A Kechter; M Hollnagel; L Bullinger; K Döhner; H Döhner; M Feuring-Buske; C Buske
Journal:  Leukemia       Date:  2016-04-11       Impact factor: 11.528

2.  Unexpected redundancy of Gpr56 and Gpr97 during hematopoietic cell development and differentiation.

Authors:  Antonio Maglitto; Samanta A Mariani; Emma de Pater; Carmen Rodriguez-Seoane; Chris S Vink; Xianhua Piao; Mari-Liis Lukke; Elaine Dzierzak
Journal:  Blood Adv       Date:  2021-02-09

3.  High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.

Authors:  Shruti Daga; Angelika Rosenberger; Franz Quehenberger; Nina Krisper; Barbara Prietl; Andreas Reinisch; Armin Zebisch; Heinz Sill; Albert Wölfler
Journal:  Cancer Med       Date:  2019-03-07       Impact factor: 4.452

Review 4.  The role of GPR56/ADGRG1 in health and disease.

Authors:  Abhishek Kumar Singh; Hsi-Hsien Lin
Journal:  Biomed J       Date:  2021-05-04       Impact factor: 4.910

5.  CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia.

Authors:  Lixiazi He; Christian Arnold; Judith Thoma; Christian Rohde; Maksim Kholmatov; Swati Garg; Cheng-Chih Hsiao; Linda Viol; Kaiqing Zhang; Rui Sun; Christina Schmidt; Maike Janssen; Tara MacRae; Karin Huber; Christian Thiede; Josée Hébert; Guy Sauvageau; Julia Spratte; Herbert Fluhr; Gabriela Aust; Carsten Müller-Tidow; Christof Niehrs; Gislene Pereira; Jörg Hamann; Motomu Tanaka; Judith B Zaugg; Caroline Pabst
Journal:  EMBO Mol Med       Date:  2022-03-07       Impact factor: 12.137

6.  Functional screen identifies regulators of murine hematopoietic stem cell repopulation.

Authors:  Per Holmfeldt; Miguel Ganuza; Himangi Marathe; Bing He; Trent Hall; Guolian Kang; Joseph Moen; Jennifer Pardieck; Angelica C Saulsberry; Alba Cico; Ludovic Gaut; Daniel McGoldrick; David Finkelstein; Kai Tan; Shannon McKinney-Freeman
Journal:  J Exp Med       Date:  2016-02-15       Impact factor: 14.307

7.  Overexpressing IRS1 in Endothelial Cells Enhances Angioblast Differentiation and Wound Healing in Diabetes and Insulin Resistance.

Authors:  Sayaka Katagiri; Kyoungmin Park; Yasutaka Maeda; Tata Nageswara Rao; Mogher Khamaisi; Qian Li; Hisashi Yokomizo; Akira Mima; Luca Lancerotto; Amy Wagers; Dennis P Orgill; George L King
Journal:  Diabetes       Date:  2016-05-23       Impact factor: 9.461

8.  Attenuation of PKCδ enhances metabolic activity and promotes expansion of blood progenitors.

Authors:  Tata Nageswara Rao; Manoj K Gupta; Samir Softic; Leo D Wang; Young C Jang; Thomas Thomou; Olivier Bezy; Rohit N Kulkarni; C Ronald Kahn; Amy J Wagers
Journal:  EMBO J       Date:  2018-11-16       Impact factor: 11.598

Review 9.  Role of ADGRG1/GPR56 in Tumor Progression.

Authors:  Kwai-Fong Ng; Tse-Ching Chen; Martin Stacey; Hsi-Hsien Lin
Journal:  Cells       Date:  2021-11-29       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.